Zantac

    Want more claimants? Fill out the form to get free info.
    By submitting this form, I consent that I may be contacted by email and/or phone (including a wireless number) using automated technology, by Adwire Media and/or third-party partners. If I have provided my cell number I also acknowledge that I may be contacted via text message. Message and data rates may apply. My consent is not a requirement for receipt of services.*

    Zantac Criteria

    The criteria below is a list of standard filters. We can customize the criteria based on your requirements.
    • Took brand-named Zantac (ranitidine)
    • Diagnosed with one of the following cancers after taking Zantac
      • Liver cancer
      • Kidney cancer
      • Bladder cancer
      • Gastric cancer
      • Esophageal cancer
      • Stomach cancer
      • Colon cancer
      • Colorectal cancer
      • Intestinal cancer
      • Anal cancer
      • Testicular cancer
      • Pancreatic cancer
      • Gallbladder cancer
      • Other digestive tract cancer
    • Not diagnosed with cancer prior to Zantac use
    • No legal representation

    Zantac Background Information

    Over-the-Counter (OTC) Zantac

    • 1993 – GSK and Warner Lambert enter joint venture for OTC Zantac
    • 1995 – First approval of OTC Zantac
    • 1998 – GSK and Warner Lambert split; WL takes Zantac trademark in the U.S.
    • 2000 – Pfizer acquires Warner Lambert
    • 2006 – Boehringer Ingelheim acquires OTC Zantac from Pfizer
    • 2017 – Sanofi-AS acquires Zantac

    Over-the-Counter (OTC) Zantac

    • 1993 – GSK and Warner Lambert enter joint venture for OTC Zantac
    • 1995 – First approval of OTC Zantac
    • 1998 – GSK and Warner Lambert split; WL takes Zantac trademark in the U.S.
    • 2000 – Pfizer acquires Warner Lambert
    • 2006 – Boehringer Ingelheim acquires OTC Zantac from Pfizer
    • 2017 – Sanofi-AS acquires Zantac
    Case Option Case Number Date Filed Count Filed In Kind of Case Alleged Injury (for PI) Filing Firm
    Galimidi vs. Sanofi US Services, Inc., et al. 95707176 9/13/2019 Circuit Court of the 11th Judicial Circuit In and For Miami-Dade County, Florida Personal Injury Breast Cancer (Male) Levin Citron Rodal, PLLC
    Garza et al v. Sanofi-Aventis U.S. LLC et al 5:19-cv-05772-BLF 9/13/2019 Northern District of California Class Action N/A HAGENS BERMAN SOBOL SHAPIRO LLP
    Lopez Flores v. Sanofi US Services Inc. et al 0:19-cv-62313-FAM 9/17/2019 Southern District of Florida Personal Injury Breast Cancer Levin Citron Rodal, PLLC
    SANTORELLA et al v. SANOFI-AVENTIS U.S. LLC et al 3:19-cv-18149 9/20/2019 District of New Jersey Class Action N/A HAGENS BERMAN SOBOL SHAPIRO LLP
    Dimesky et al v. Sanofi-Aventis U.S. LLC et al 3:19-cv-01517 9/26/2019 District of Connecticut Class Action N/A HAGENS BERMAN SOBOL SHAPIRO LLP
    Kerzer v. Sanofi-Aventis U.S. LLC. et al 1:19-cv-24092-RNS 13/3/2019 Southern District of Florida Personal Injury Kidney Cancer COLSON HICKS EIDSON, P.A.; AYLSTOCK, WITKIN, KREIS & OVERHOLTZ, PLLC
    Hansen v.Boehringer Ingelheim Pharmaceuticals, Inc. et al 2:19-cv-02069-KJM-AC 10/15/2019 Eastern District of California Personal Injury Colorectal Cancer BAUM, HEDLUND, AEISTEI & GOLDMAN, P.C.

    CONTACT US

    We welcome you to contact Mass Torts USA for more information
    about our products and services.

    OUR ADDRESS

    DROP US A LINE